Discovery and characterization of a novel highly potent and selective type II native and drug-resistant V299L mutant BCR-ABL inhibitor (CHMFL-ABL-039) for Chronic Myeloid Leukemia (CML)
| Image |  |
|---|---|
| Description | scientific article published on 20 March 2019 |
| Author/s |
author: Jing Liu Qingsong Liu |
| Publication date | March 20, 2019 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |